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Natural matrices are important sources of new antitumor and antimicrobial compounds. Species such as Laurus nobilis L. (laurel)
might be used for this purpose, considering its medicinal properties. Herein, in vitro activity against human tumor cell lines,
bacteria, and fungi was evaluated in enriched phenolic extracts. Specifically, methanol and aqueous extracts of wild and cultivated
samples of L. nobilis were compared considering different phenolic groups. Principal component analysis (PCA) was applied to
understand how each extract acts differentially against specific bacteria, fungi, and selected human tumor cell lines. In general, the
extract type induced the highest differences in bioactivity of laurel samples. However, from the PCA biplot, it became clear that wild
laurel samples were higher inhibitors of tumor cell lines (HeLa, MCF7, NCI-H460, and HCT15). HepG2 had the same response to
laurel from wild and cultivated origin. It was also observed that methanolic extracts tended to have higher antimicrobial activity,
except against A. niger, A. fumigatus, and P. verrucosum. The differences in bioactivity might be related to the higher phenolic
contents in methanolic extracts. These results allow selecting the extract type and/or origin with highest antibacterial, antifungal,
and antitumor activity.
1. Introduction
Laurus nobilis L. (Lauraceae), commonly known as laurel or
bay leaves, is a native plant from the SouthernMediterranean
region, found in warm climate regions with high rainfall [1].
It is one of the most widely used culinary spices for seasoning
of meat products, soups, and fishes but is also used as an
ornamental plant, especially in Europe and USA. It is also
commercially grown in Turkey, Algeria, Morocco, Portugal,
Spain, Italy, France, and Mexico [2–4]. The dry laurel and
their infusions are traditionally used to treat gastrointestinal
problems, such as epigastric, bloating, digestion, eructation,
and flatulence problems. It also possesses anticonvulsive and
antiepileptic activities and stimulant and narcotic properties
[2, 5, 6]. The ability to suppress high blood sugar and prevent
not only migraines and headaches but also bacterial and
fungal infections has also been reported [3, 7].
Natural matrices, like L. nobilis, are rich sources of
bioactive compounds. In fact, nearly 60% of the antitumor
and anti-infectious drugs available on the market, or under
clinical trial, are from natural origin [6, 8]. The biological
activities of plant extracts are well recognized, namely, their
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antifungal, antimicrobial, insecticidal, and cytostatic effects.
Accordingly, the bioactivity of plant extracts is often explored
in a multifactorial manner [8, 9].
Nowadays, there is a worldwide concern about the use of
synthetic chemical compounds as antitumor agents due to
their potential negative health effects, opening ways to use
plants as sources of natural compounds with similar activity
[10]. On the other hand, the indiscriminate use of antibiotics
to treat bacterial and fungal infections led to the emergence
and spread of organisms resistant to broad-spectrum antibi-
otics, demanding new antimicrobial agents [11, 12].
There are some reports on the antitumor potential of L.
nobilis essential oil [13, 14], methanolic [15], ethanol, and
aqueous extracts [8]. However, most publications regard
isolated compounds [6, 16, 17]. For instance, sesquiterpene
lactones and methyl esters isolated from L. nobilis leaves
exhibited moderate-to-significant cytotoxicity towards K562
leukemia cells [16]. Likewise, there are a considerable number
of reports on the antimicrobial effects of L. nobilis essential
oil [1, 4, 9, 18–21], aqueous [11], ethanolic [12, 22, 23], and
methanolic extracts [24]. The antimicrobial activity of L.
nobilis is mainly related to terpenes and phenolic compounds
[7, 24–26].
Despite the previous findings, and as far as we know,
this is the first study exploring in vitro antimicrobial and
antitumor activities from cultivated and wild L. nobilis
enriched phenolic extracts. Furthermore, it was intended to
compare the differentiated activity of each extract against
specific bacteria, fungi, and selected human tumor cell lines,
using principal component analysis.
2. Materials and Methods
2.1. Samples. Cultivated Laurus nobilis L. samples (leaves)
were purchased from Ervital (Castro Daire, Portugal), which
produces Mediterranean herbs using organic farming princi-
ples and methods. The wild samples (leaves) were collected
in Braganc¸a, Portugal, and further lyophilized (FreeZone 4.5,
Labconco, KS, USA). Each sample was reduced to a fine dried
powder (20 mesh) and stored (7∘C) until further use.
2.2. Standards and Reagents. Fetal bovine serum (FBS),
L-glutamine, Hank’s balanced salt solution (HBSS), trypsin-
EDTA (ethylenediaminetetraacetic acid), nonessential
amino acids solution (2mM), penicillin/streptomycin
solution (100U/mL and 100mg/mL, resp.), RPMI-1640,
and DMEM media were from HyClone (Logan, UT, USA).
Acetic acid, ellipticine, sulforhodamine B (SRB), trypan blue,
trichloroacetic acid (TCA), and Tris were from Sigma Chem-
ical Co. (Saint Louis, USA). Mueller-Hinton agar (MH) and
malt agar (MA)were obtained from the Institute of Immunol-
ogy and Virology, Torlak (Belgrade, Serbia). Dimethyl
sulfoxide (DMSO) (Merck KGaA, Germany) was used as a
solvent. Phosphate buffered saline (PBS) was obtained from
Sigma Chemical Co. (St. Louis, USA). Methanol and all other
chemicals and solvents were of analytical grade and pur-
chased from common sources.Water was treated in aMilli-Q
water purification system (TGI Pure Water Systems, USA).
2.3. Extracts Preparation. Methanolic extracts were obtained
from cultivated and wild plant material. Each sample (≈1 g)
was extracted by stirring with 30mL of methanol, at room
temperature, 150 rpm for 1 h.The extract was filtered through
Whatman number 4 paper. The residue was then reextracted
with additional 30mL of methanol. The combined extracts
were evaporated at 35∘C (rotary evaporator Bu¨chi R-210,
Flawil, Switzerland) to dryness.
For aqueous extracts, plant material (≈1 g) was added to
200mL of boiling distilled water, left to stand for 5min out of
the heating source, and then filtered under reduced pressure.
The obtained extract was frozen and lyophilized.
Methanolic and aqueous extracts were redissolved in
water (8mg/mL) or 5% DMSO (10mg/mL) for antitumor
and antimicrobial activity evaluation, respectively. The final
solutions were further diluted to different concentrations for
bioactivity evaluation.
2.4. Antitumor Activity and Hepatotoxicity. Five human
tumor cell lines were tested: MCF7 (breast adenocarcinoma),
NCI-H460 (non-small cell lung cancer), HCT15 (colon carci-
noma), HeLa (cervical carcinoma), and HepG2 (hepatocellu-
lar carcinoma). Cells were routinely maintained as adherent
cell cultures in RPMI-1640 medium containing 10% heat-
inactivated FBS and 2mM glutamine (MCF7, NCI-H460,
and HCT15) or in DMEM supplemented with 10% FBS,
2mM glutamine, 100U/mL penicillin, and 100mg/mL strep-
tomycin (HeLa and HepG2 cells), at 37∘C, in a humidified
air incubator containing 5% CO
2
. Each cell line was plated
at an appropriate density (7.5 × 103 cells/well forMCF-7, NCI-
H460, andHCT15 or 1.0× 104 cells/well forHeLa andHepG2)
in 96-well plates. Sulforhodamine B assay was performed
according to a procedure previously described by the authors
[27]. Ellipticine was used as positive control.
For hepatotoxicity evaluation, a cell culture (PLP2) was
prepared froma freshly harvested porcine liver obtained from
a local slaughter house, according to an established procedure
[27]. Cell culture was continued with direct monitoring
every 2-3 days using a phase contrast microscope. Before
confluence was reached, cells were subcultured and plated in
96-well plates at a density of 1.0 × 104cells/well and cultivated
in DMEM medium with 10% FBS, 100U/mL penicillin, and
100 𝜇g/mL streptomycin. Ellipticine was used as positive
control. The results were expressed in GI
50
values (sample
concentration that inhibited 50% of the net cell growth).
2.5. Antibacterial Activity. The following gram-positive bac-
teria: Staphylococcus aureus (ATCC 6538), Bacillus cereus
(clinical isolate), Micrococcus flavus (ATCC 10240), and
Listeriamonocytogenes (NCTC 7973) and gram-negative bac-
teria:Escherichia coli (ATCC35210),Pseudomonas aeruginosa
(ATCC 27853), Salmonella typhimurium (ATCC 13311), and
Enterobacter cloacae (ATCC 35030) were used. The microor-
ganisms were obtained from the Mycological laboratory,
Department of Plant Physiology, Institute for Biological
Research “Sinisa Stankovic´” (IBRSS), University of Belgrade,
Serbia.
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Theminimum inhibitory (MIC) andminimum bacterici-
dal (MBC) concentrations were determined by the microdi-
lutionmethod. Briefly, fresh overnight culture of bacteria was
adjusted by the spectrophotometer to a concentration of 1 ×
105 CFU/mL. The requested CFU/mL corresponded to a
bacterial suspension determined in a spectrophotometer at
625 nm (OD625). Dilutions of inocula were cultured on a
solid medium to verify the absence of contamination and
check the validity of the inoculum.Different solvent dilutions
of methanolic extract/fractions were placed in the wells con-
taining 100 𝜇L of tryptic soy broth (TSB) and afterwards 10 𝜇L
of inoculum was added. The microplates were incubated for
24 h at 37∘C.The MIC of each extract was detected following
the addition of 40 𝜇L of iodonitrotetrazolium chloride (INT)
(0.2mg/mL) and incubation at 37∘C for 30min. The lowest
concentration that produced a significant inhibition (around
50%) of the growth of the bacteria in comparison with the
positive control was identified as the MIC. The minimum
inhibitory concentrations (MICs) obtained from the suscep-
tibility testing of various bacteria to tested extract/fraction
were determined also by a colorimetric microbial viability
assay based on reduction of INT color and compared with
positive control for each bacterial strain [28, 29]. MBC was
determined by serial subcultivation of 10 𝜇L into microplates
containing 100 𝜇L of TSB. The lowest concentration not
showing growth after this subculturing was read as the MBC.
Standard drugs, namely, streptomycin and ampicillin, were
used as positive controls. DMSO (5%) was used as negative
control.
2.6. Antifungal Activity. For the antifungal bioassays, the
followingmicrofungi were used:Aspergillus fumigatus (1022),
Aspergillus ochraceus (ATCC 12066), Aspergillus versicolor
(ATCC 11730), Aspergillus niger (ATCC 6275), Penicillium
funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC
9112), Penicillium verrucosum var. cyclopium (food isolate),
and Trichoderma viride (IAM 5061). The organisms were
obtained from the Mycological Laboratory, Department of
Plant Physiology, IBRSS, Belgrade, Serbia. The micromycetes
were maintained on malt agar (MA) and the cultures were
stored at 4∘C and subcultured once a month [30].
The fungal spores were washed from the surface of agar
plates with sterile 0.85% saline containing 0.1% Tween 80
(v/v). The spore suspension was adjusted with sterile saline
(≈1.0 × 103/𝜇L per well). The inocula were stored at 4∘C for
further use. Dilutions of the inocula were cultured on solid
MA to verify the absence of contamination and to check
the validity of the inoculum. MICs determination was per-
formed by a serial dilution technique using 96-wellmicrotitre
plates. The extract/fractions were dissolved in 5% solution
of DMSO and added to broth malt medium with fungal
inoculum. The microplates were incubated for 72 h at 28∘C.
The lowest concentrations without visible growth (at the
binocular microscope) were defined as MIC. The minimum
fungicidal concentrations (MFCs) were determined by serial
subcultivation of 2 𝜇L in microtitre plates containing 100𝜇L
of malt broth per well and further incubation for 72 h at 28∘C.
The lowest concentration with no visible growth was defined
as theMFC, indicating 99.5%killing of the original inoculum.
Bifonazole and ketoconazole were used as positive controls.
DMSO (5%) was used as negative control [31].
2.7. Statistical Analysis. For wild and cultivated plant mate-
rial, three samples were used and all the assays were carried
out in triplicate. Data were expressed as means ± standard
deviations, maintaining the decimal places allowed by the
magnitude of standard deviation.
An analysis of variance (ANOVA) with type III sums of
squares was performed using theGLM (general linearmodel)
procedure of the SPSS software.Thedependent variables were
analyzed using 2-way ANOVA with the factors “extract” (E)
and “origin” (O). When a statistically significant interaction
(E×O) was detected, the two factors were evaluated simulta-
neously by the estimated marginal means plots for the two
levels of each factor. Alternatively, if no statistical significant
interaction was verified, means were compared using results
obtained for EB and GI that were classified using a simple 𝑡-
test (after checking the equality of variances through Levene’s
test), since there were fewer than three groups.
Principal components analysis (PCA) was applied as
pattern recognition unsupervised classification method. The
number of dimensions to keep for data analysis was assessed
by the respective eigenvalues (which should be greater than
one), by Cronbach’s alpha parameter (that must be positive),
and also by the total percentage of variance (that should be
as high as possible) explained by the number of components
selected. The number of plotted dimensions was chosen in
order to allow meaningful interpretations.
All statistical tests were performed at a 5% significance
level using the SPSS software, version 20.0 (SPSS Inc.).
3. Results and Discussion
The interactions among L. nobilis origin (cultivated or wild)
and extract (methanolic or aqueous) were evaluated to verify
if these factors act together to cause changes in phenolic
composition and/or biological activities. Results are pre-
sented as the mean value of each origin (O), comprising
both extracts, as well as the mean value of each extract (E),
containing samples from both origins. When the interaction
among factors (O×E) was significant (𝑃 < 0.05), acting itself
as a source of variability, the comparison of means could
not be performed. In these cases, the presented conclusions
were drawn from the estimated marginal means (EMM)
plots obtained in each case. When the interaction was not
significant, a simple 𝑡-test (fewer than three groups) was
applied to evaluate the equality of means.
3.1. Phenolic Compound Groups Present in the Studied L.
nobilis Extracts. Table 1 summarizes the phenolic compound
groups present inmethanolic and aqueous extracts from
cultivated and wild L. nobilis, as reported in a previous
study of our research group [32]. According to those results,
cultivated samples showed higher concentrations of flavonols
(e.g., quercetin and kaempferol derivatives) and flavones
(e.g., luteolin and apigenin derivatives). On the other hand,
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Table 1: Phenolic compounds (mg/g) of different extracts of Laurus
nobilis. The results are presented as mean ± SD.
Total
flavan-3-ols
Total
flavones
Total
flavonols
Total
phenolic
Origin (O)
Cultivated 56 ± 8 4.4 ± 0.2 26 ± 2 86 ± 11
Wild 60 ± 4 2.6 ± 0.4 7 ± 2 71 ± 6
𝑃 value
(𝑛 = 18) 0.025 <0.001 <0.001 <0.001
Extract (E)
Methanolic 63.6 ± 0.4 4 ± 1 19 ± 10 86 ± 11
Aqueous 52 ± 5 3 ± 1 15 ± 9 70 ± 5
𝑃 value
(𝑛 = 18) <0.001 0.104 0.207 <0.001
O×E
𝑃 value
(𝑛 = 36) <0.001 <0.001 <0.001 <0.001
The detailed phenolic profile of all laurel samples was previously described
by Dias et al. [32].
methanolic extracts had the highest flavan-3-ols contents
(e.g., (−)-epicatechin and a procyanidin trimer with an
A-type linkage). These differences were maintained after
assembling samples according to their origin or extraction
type (Table 1), as previously explained. As it can be concluded,
cultivated samples had higher contents in total phenolics,
especially due to their higher contents in flavonols, since the
amounts in flavan-3-ols were similar for both origins. All the
quantified phenolic compound groups tended to be higher in
methanolic extracts, probably due to the higher temperature
used in aqueous extracts [33].These tendencieswere obtained
from the EMM plots since the interaction among factors was
significant in all cases.
3.2. Antitumor Activity of the Studied L. nobilis Extracts.
The interaction among factors was again significant in all
cases, except MCF7 line (Table 2). Considering each factor
individually, the origin of laurel had once more higher
influence, producing statistically significant differences in all
cases except HepG2. Wild laurel presented lower GI
50
values
than cultivated samples but also higher toxicity against non-
tumor liver primary cells (PLP2; 114 𝜇g/mL). Nevertheless,
this sample might have the potential to be used for antitumor
proposes, since the GI
50
values for hepatotoxicity were higher
than those obtained for the tumor cell lines (except HepG2).
Cultivated samples showed also antitumor activity against
NCI-H460, HCT15, and HeLa, since the corresponding GI
50
values were quite lower than the toxic concentration for
PLP2. Differences among aqueous and methanolic extracts
were only significant for HCT15 (47 𝜇g/mL in methanolic
extracts), HepG2 (144 𝜇g/mL in aqueous extracts), and PLP2
primary liver cells (99 𝜇g/mL in methanolic extracts). The
results for the breast carcinoma cell line (MCF7) showed
better results when compared to the essential oil of fruits and
leaves of wild L. nobilis from Lebanon (>400 𝜇g/mL) [13],
but lower activity than aqueous extract from wild laurel from
Jordan against the same line (88.32% at 50 𝜇g/mL) [8]. Kaileh
et al. [15] only reported that the methanolic extract of wild
laurel from Palestine showed no cytotoxicity.
3.3. Antibacterial Activity of the Studied L. nobilis Extracts.
Extract type and origin had a significant interaction in the
antibacterial activity against all species, except M. flavus
(Table 3). Cultivated and wild L. nobilis were active against
all bacteria strains withMICs of 0.04–0.12mg/mL and 0.046–
0.16mg/mL, respectively. TheMBCs were higher than MICs,
varying from 0.09 to 0.39mg/mL for cultivated laurel and
from 0.1 to 0.29mg/mL for wild samples. The effect of laurel
origin per sewas not significant for S. aureus (MIC andMBC),
E. coli (MBC), and E. cloacae (MBC). Methanolic extracts
were better inhibitors (0.012–0.12mg/mL) of bacterial growth
than the aqueous extracts (0.07–0.20mg/mL), except for
M. flavus (𝑃 = 0.858). In all cases, the inhibitory and
bactericidal activities were higher than those obtained for
the standard ampicillin. In the case of streptomycin, the
inhibitory activity of the extracts was also higher, except for
S. aureus (cultivated, wild, and aqueous samples), B. cereus
(wild and aqueous samples), and L. monocytogenes (aqueous
extract). The results were similar for bactericidal activity,
with streptomycin showing higher activity against S. aureus
(cultivated, wild, and aqueous samples), B. cereus (wild and
aqueous samples), and L. monocytogenes (cultivated and
aqueous samples). The bacterial strains more susceptible to
cultivated andwild samples were E. cloacae and P. aeruginosa,
respectively. On the other hand, methanolic and aqueous
extractswere particularly active against S. aureus and M.
flavus, respectively. Regarding MBC, the results were the
same, except for aqueous extract, which proved to have
highest bactericidal effect against E. cloacae (0.1mg/mL).
All presentedMICsweremuch better than those obtained
by Al-Hussaini and Mahasneh [12] on the ethanolic extracts
of L. nobilis from Jordan against S. aureus, B. cereus, E.
coli, S. typhimurium, and P. aeruginosa. The same applies to
the results obtained by El Malti and Amarouch [23] on the
ethanolic extracts of laurel fromMorocco against B. cereus, S.
aureus, L. monocytogenes, E. cloacae, E. coli, and P. aeruginosa
(>2mg/mL). The inhibitory activity described herein is also
higher than that reported using essential oils of laurel from
Turkey (MIC values of 5mg/mL against E. coli, S. aureus, and
P. aeruginosa) [9]. However, better results were obtained by
Adwan and Mhanna using aqueous extracts of laurel from
Palestine against S. aureus bacterial strain (<6.1 × 10−3mg/L),
but only when conjugated with enrofloxacin and cephalexin
antibiotics [11].
3.4. Antifungal Activity of the Studied L. nobilis Extracts.
The interaction among factors was once more significant in
almost all cases, except MIC values for P. ochrochloron (𝑃 =
0.278) and MBC values for A. niger (𝑃 = 0.312) and P.
ochrochloron (𝑃 = 0.052) (Table 4). The inhibitory activity
on fungal growth was more influenced by extract type, as it
can be concluded from the statistically significant differences
verified in all cases, except A. ochraceus (𝑃 = 0.077).
Methanolic extracts were more active against A. versicolor,
BioMed Research International 5
Table 2: Antitumor activity and hepatotoxicity (GI50, 𝜇g/mL) of different extracts of Laurus nobilis. The results are presented as mean ± SD1.
MCF7 NCI-H460 HCT15 HeLa HepG2 PLP2-hepatotoxicity
Origin (O)
Cultivated 187 ± 12a 83 ± 13 56 ± 1 119 ± 21 185 ± 7 195 ± 85
Wild 88 ± 5b 73 ± 19 44 ± 7 69 ± 9 166 ± 59 114 ± 29
𝑃 value (𝑛 = 18) <0.001 0.077 <0.001 <0.001 0.171 <0.001
Extract (E)
Methanolic 140 ± 50 74 ± 21 47 ± 10 100 ± 41 207 ± 17 99 ± 14
Aqueous 135 ± 53 81 ± 10 53 ± 2 88 ± 11 144 ± 37 210 ± 70
𝑃 value (𝑛 = 18) 0.773 0.254 0.011 0.242 <0.001 <0.001
O×E
𝑃 value (𝑛 = 36) 0.261 <0.001 <0.001 <0.001 <0.001 <0.001
Ellipticine 0.91 ± 0.04 1.42 ± 0.01 1.91 ± 0.05 1.14 ± 0.05 3.2 ± 0.5 2.06 ± 0.03
1Means within a column with different letters differ significantly (𝑃 < 0.001).
Trichoderma viride, P. funiculosum, and P. ochrochloron,
while aqueous extracts were better in all remaining cases
(except, of course, A. ochraceus, which gave no differences).
Cultivated and wild samples gave MICs varying from 0.01 to
0.17mg/mL and from 0.02 to 0.3mg/mL, respectively. In the
cases revealing statistically significant differences, cultivated
laurel samples gave higher inhibitory activity.
Concerning fungicidal activity, MFCs varied from 0.03
to 0.6mg/mL and from 0.03 to 0.5mg/mL for cultivated and
wild samples, respectively. Both origins had the same effect on
A. versicolor, A. niger, and T. viride. Comparing extract types,
MFC varied from 0.016 to 0.7mg/mL (methanolic extracts)
and from 0.046 to 0.3mg/mL (aqueous extracts). Like it was
observed for inhibitory activity, the fungicidal action was
more influenced by the type of extract when compared with
laurel origin (except P. funiculosum).
For both origins and extracts, A. fumigatus (only cul-
tivated and aqueous samples in the case of bifonazole),
A. versicolor, A. ochraceus, T. viride, P. funiculosum, and
P. ochrochloron showed better activity than bifonazole and
ketoconazole. A. versicolor and T. viride were the most
susceptible fungal strains, while A. niger and P. verrucosum
showed the highest resistance. Al-Hussaini and Mahasneh
[12] and Simic´ et al. [21] reported better results on ethanolic
extracts and essential oil, respectively, of laurel leaves from
Jordan and Serbia and Montenegro against A. niger.
3.5. Principal Component Analysis (PCA). After analysing
individually each bioactivity indicator and the contents in
phenolic compounds, PCA was applied to understand the
true effect of either origin or extract type in a global manner.
That is, instead of evaluating individual changes caused in
each bioactivity indicator or phenolic compounds group, it
was intended to obtain an integrated output dealing with all
the effects at once.The plot of component loadings forextract
type was designed with the first two dimensions (first:
Cronbach’s 𝛼, 0.965; eigenvalue, 17.194; second: Cronbach’s
𝛼, 0.950; eigenvalue, 13.721), which included most variance
of data (first: 40.94%; second: 32.67%). The third and fourth
dimensions, despite being significant, were not plotted due to
the complexity of the corresponding output.The distribution
of objects (Figure 1) indicates a clear separation ofmethanolic
and aqueous extracts (black and grey ellipses). Furthermore,
objects corresponding to wild and cultivated samples were
clearly separated within each type of extract. The assignment
of each set of objects to either wild or cultivated samples was
done according to the tabled object scores (data not shown).
Group corresponding to cultivated samples extracted
with methanol (solid grey line ellipse) was characterized
by the high amounts of bioactive compounds, specifically
flavonols, flavones, and total phenolics, and its high bioactiv-
ity against bacteria (B. cereus,MIC andMBC, S. typhimurium,
MIC and MBC, E. coli, MIC, E. cloacae, MIC, and L.
monocytogenes, MIC) and fungi (A. ochraceus, MIC and
MFC, A. versicolor, MIC, and P. funiculosum, MFC).
The most distinctive features in cultivated samples
extracted with water (solid black line ellipse) were the
low content in flavan-3-ols, despite having high antifungal
activity against A. fumigatus and A. niger (MIC and MFC).
A third group (dashed grey line ellipse), corresponding
to wild samples extracted with methanol, was characterized
as having high antibacterial (S. aureus, MIC and MBC, L.
monocytogenes, MBC, and P. aeruginosa, MIC), antifungal
(T. viride, MIC and MFC, P. ochrochloron, MFC, and P.
funiculosum, MIC), and antitumoral activities (HCT15).
The high bioactivity of wild methanolic extracts might be
related to their high content in flavan-3-ols, mainly epicate-
chin and procyanidin trimer with an A-linkage [32], which
were previously reported as having strong antibacterial activ-
ity [34, 35]. Curiously, these extracts had an activity opposite
to that demonstrated by cultivated samples extracted with
water, which might indicate that the A. fumigatus and A.
flavus are poorly susceptible to flavan-3-ols.
Similarly, wild samples extracted with water (dashed
black line ellipse) had the reverse behavior in comparison to
cultivated samples extracted with methanol. These aqueous
extracts were mostly active against P. verrucosum, which
seemed to have low susceptibility to favonols, flavones, and
total phenolics and generally high resistance against the
tested extracts (please see Section 3.4).
6 BioMed Research International
Ta
bl
e
3:
A
nt
ib
ac
te
ria
la
ct
iv
ity
(M
IC
an
d
M
BC
,m
g/
m
L)
of
di
ffe
re
nt
ex
tr
ac
ts
of
La
ur
us
no
bi
lis
.Th
er
es
ul
ts
ar
ep
re
se
nt
ed
as
m
ea
n
±
SD
1 .
St
ap
hy
lo
co
cc
us
au
re
us
Ba
cil
lu
s
ce
re
us
M
icr
oc
oc
cu
s
fla
vu
s
Li
ste
ria
m
on
oc
yt
og
en
es
Ps
eu
do
m
on
as
ae
ru
gi
no
sa
Sa
lm
on
ell
a
ty
ph
im
ur
iu
m
Es
ch
er
ich
ia
co
li
En
te
ro
ba
ct
er
clo
ac
ae
M
IC
O
rig
in
(O
)
Cu
lti
va
te
d
0
.
0
6
±
0
.
0
4
0
.
0
8
±
0
.
0
4
0
.
0
4
8
±
0
.
0
0
5
0
.
1
±
0
.
1
0
.
0
8
±
0
.
0
4
0
.
0
8
±
0
.
0
3
0
.
1
2
±
0
.
0
2
0
.
0
4
±
0
.
0
1
W
ild
0
.
0
5
±
0
.
0
5
0
.
1
1
±
0
.
0
1
0
.
1
0
1
±
0
.
0
0
5
0
.
1
6
±
0
.
0
5
0
.
0
4
6
±
0
.
0
0
3
0
.
1
1
±
0
.
0
1
0
.
1
6
±
0
.
0
5
0
.
0
8
±
0
.
0
5
𝑃
va
lu
e(
𝑛
=
1
8
)
0.
61
9
0.
00
1
<
0.
00
1
0.
03
0
0.
00
1
<
0.
00
1
0.
00
2
0.
00
4
Ex
tr
ac
t(
E)
M
et
ha
no
lic
0
.
0
1
2
±
0
.
0
0
5
0
.
0
8
±
0
.
0
4
0
.
0
8
±
0
.
0
3
0
.
0
6
±
0
.
0
4
0
.
0
4
6
±
0
.
0
0
3
0
.
0
7
±
0
.
0
3
0
.
1
2
±
0
.
0
2
0
.
0
3
±
0
.
0
1
Aq
ue
ou
s
0
.
1
0
±
0
.
0
1
0
.
1
1
±
0
.
0
1
0
.
0
7
±
0
.
0
3
0
.
2
0
±
0
.
0
2
0
.
0
8
±
0
.
0
3
0
.
1
1
±
0
.
0
1
0
.
1
6
±
0
.
0
5
0
.
0
8
±
0
.
0
5
𝑃
va
lu
e(
𝑛
=
1
8
)
<
0.
00
1
0.
00
1
0.
85
8
<
0.
00
1
0.
00
1
<
0.
00
1
0.
00
9
0.
00
2
O
×
E
𝑃
va
lu
e(
𝑛
=
3
6
)
0.
00
2
<
0.
00
1
0.
21
2
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
A
m
pi
ci
lli
n
0
.
2
5
±
0
.
0
2
0
.
2
5
±
0
.
0
3
0
.
2
5
±
0
.
0
4
0
.
3
7
±
0
.
0
5
0
.
7
4
±
0
.
0
5
0
.
3
7
±
0
.
0
2
0
.
2
5
±
0
.
0
1
0
.
3
7
±
0
.
0
4
St
re
pt
om
yc
in
0
.
0
4
±
0
.
0
1
0
.
0
9
±
0
.
0
1
0
.
1
7
±
0
.
0
2
0
.
1
7
±
0
.
0
1
0
.
1
7
±
0
.
0
1
0
.
1
7
±
0
.
0
2
0
.
1
7
±
0
.
0
2
0
.
2
6
±
0
.
0
3
M
BC
O
rig
in
(O
)
Cu
lti
va
te
d
0
.
1
6
±
0
.
0
4
0
.
1
5
±
0
.
0
4
0
.
1
1
±
0
.
0
1
0
.
3
9
±
0
.
0
2
0
.
1
8
±
0
.
0
2
0
.
1
6
±
0
.
0
5
0
.
2
0
±
0
.
0
2
0
.
0
9
±
0
.
0
3
W
ild
0
.
1
±
0
.
1
0
.
1
9
±
0
.
0
2
0
.
2
0
±
0
.
0
1
0
.
2
9
±
0
.
0
5
0
.
1
0
±
0
.
0
1
0
.
2
1
±
0
.
0
2
0
.
2
±
0
.
1
0
.
1
±
0
.
1
𝑃
va
lu
e(
𝑛
=
1
8
)
0.
26
2
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
0.
00
2
0.
76
4
0.
11
1
Ex
tr
ac
t(
E)
M
et
ha
no
lic
0
.
0
7
±
0
.
0
5
0
.
1
5
±
0
.
0
4
0
.
1
6
±
0
.
0
5
0
.
3
±
0
.
1
0
.
1
4
±
0
.
0
4
0
.
1
7
±
0
.
0
5
0
.
1
±
0
.
1
0
.
0
8
±
0
.
0
4
Aq
ue
ou
s
0
.
2
1
±
0
.
0
2
0
.
1
9
±
0
.
0
1
0
.
1
5
±
0
.
0
5
0
.
3
7
±
0
.
0
3
0
.
1
5
±
0
.
0
5
0
.
2
1
±
0
.
0
1
0
.
3
±
0
.
1
0
.
1
±
0
.
1
𝑃
va
lu
e(
𝑛
=
1
8
)
<
0.
00
1
<
0.
00
1
0.
46
1
0.
00
5
0.
69
6
0.
00
8
<
0.
00
1
0.
04
1
O
×
E
𝑃
va
lu
e(
𝑛
=
3
6
)
<
0.
00
1
<
0.
00
1
0.
71
9
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
A
m
pi
ci
lli
n
0
.
3
7
±
0
.
0
4
0
.
3
7
±
0
.
0
5
0
.
3
7
±
0
.
0
4
0
.
4
9
±
0
.
0
5
1
.
2
±
0
.
1
0
.
4
9
±
0
.
0
5
0
.
4
9
±
0
.
0
4
0
.
7
4
±
0
.
0
5
St
re
pt
om
yc
in
0
.
0
9
±
0
.
0
1
0
.
1
7
±
0
.
0
2
0
.
3
4
±
0
.
0
5
0
.
3
4
±
0
.
0
4
0
.
3
4
±
0
.
0
3
0
.
3
4
±
0
.
0
5
0
.
3
4
±
0
.
0
4
0
.
5
2
±
0
.
0
5
1
M
ea
ns
w
ith
in
ac
ol
um
n
w
ith
di
ffe
re
nt
le
tte
rs
di
ffe
rs
ig
ni
fic
an
tly
(𝑃
<
0
.
0
5
).
BioMed Research International 7
Ta
bl
e
4:
A
nt
ifu
ng
al
ac
tiv
ity
(M
IC
an
d
M
FC
,m
g/
m
L)
of
di
ffe
re
nt
ex
tr
ac
ts
of
La
ur
us
no
bi
lis
.Th
er
es
ul
ts
ar
ep
re
se
nt
ed
as
m
ea
n
±
SD
1 .
As
pe
rg
ill
us
fu
m
ig
at
us
As
pe
rg
ill
us
ve
rs
ico
lo
r
As
pe
rg
ill
us
oc
hr
ac
eu
s
As
pe
rg
ill
us
ni
ge
r
Tr
ich
od
er
m
a
vi
rid
e
Pe
ni
cil
liu
m
fu
ni
cu
lo
su
m
Pe
ni
cil
liu
m
oc
hr
oc
hl
or
on
Pe
ni
cil
liu
m
ve
rr
uc
os
um
M
IC
O
rig
in
(O
)
Cu
lti
va
te
d
0
.
0
7
±
0
.
0
5
0
.
0
1
±
0
.
0
1
0
.
0
4
±
0
.
0
1
0
.
3
±
0
.
2
0
.
0
2
±
0
.
0
1
0
.
0
3
±
0
.
0
1
0
.
1
2
±
0
.
0
2
0
.
1
7
±
0
.
0
5
W
ild
0
.
2
±
0
.
1
0
.
0
2
±
0
.
0
1
0
.
0
4
8
±
0
.
0
0
4
0
.
3
±
0
.
2
0
.
0
2
±
0
.
0
1
0
.
0
3
±
0
.
0
2
0
.
1
1
±
0
.
0
2
0
.
2
0
±
0
.
0
2
𝑃
va
lu
e(
𝑛
=
1
8
)
<
0.
00
1
0.
00
5
<
0.
00
1
0.
60
3
0.
16
3
0.
40
7
0.
05
4
0.
00
5
Ex
tr
ac
t(
E)
M
et
ha
no
lic
0
.
2
±
0
.
1
0
.
0
0
9
±
0
.
0
0
3
0
.
0
4
±
0
.
0
1
0
.
4
7
±
0
.
0
1
0
.
0
0
8
±
0
.
0
0
5
0
.
0
1
7
±
0
.
0
0
5
0
.
1
0
±
0
.
0
1
0
.
2
0
±
0
.
0
2
Aq
ue
ou
s
0
.
0
6
±
0
.
0
4
0
.
0
2
4
±
0
.
0
0
5
0
.
0
4
5
±
0
.
0
0
2
0
.
0
7
±
0
.
0
4
0
.
0
2
9
±
0
.
0
0
2
0
.
0
4
8
±
0
.
0
0
2
0
.
1
2
±
0
.
0
2
0
.
1
7
±
0
.
0
5
𝑃
va
lu
e(
𝑛
=
1
8
)
<
0.
00
1
<
0.
00
1
0.
07
7
<
0.
00
1
<
0.
00
1
<
0.
00
1
0.
00
8
0.
00
7
O
×
E
𝑃
va
lu
e(
𝑛
=
3
6
)
<
0.
00
1
0.
00
3
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
0.
27
8
<
0.
00
1
Bi
fo
na
zo
le
0
.
1
5
±
0
.
0
1
0
.
1
0
±
0
.
0
1
0
.
1
5
±
0
.
0
2
0
.
1
5
±
0
.
0
1
0
.
1
5
±
0
.
0
1
0
.
2
0
±
0
.
0
3
0
.
2
0
±
0
.
0
2
0
.
1
0
±
0
.
0
1
Ke
to
co
na
zo
le
0
.
2
0
±
0
.
0
2
0
.
2
0
±
0
.
0
3
1
.
5
±
0
.
1
0
.
2
0
±
0
.
0
2
1
.
0
±
0
.
1
0
.
2
0
±
0
.
0
2
2
.
5
±
0
.
3
0
.
2
0
±
0
.
0
4
M
FC
O
rig
in
(O
)
Cu
lti
va
te
d
0
.
2
±
0
.
1
0
.
0
5
±
0
.
0
3
0
.
0
8
±
0
.
0
3
0
.
4
±
0
.
4
0
.
0
3
±
0
.
0
1
0
.
1
0
±
0
.
0
2
0
.
2
3
±
0
.
0
2
0
.
6
±
0
.
3
W
ild
0
.
4
±
0
.
1
0
.
0
4
±
0
.
0
1
0
.
1
1
±
0
.
0
1
0
.
5
±
0
.
3
0
.
0
3
±
0
.
0
2
0
.
1
1
±
0
.
0
2
0
.
2
0
±
0
.
0
2
0
.
4
0
±
0
.
0
3
𝑃
va
lu
e(
𝑛
=
1
8
)
<
0.
00
1
0.
09
1
<
0.
00
1
0.
19
6
0.
50
0
0.
02
7
<
0.
00
1
0.
04
1
Ex
tr
ac
t(
E)
M
et
ha
no
lic
0
.
3
±
0
.
1
0
.
0
2
1
±
0
.
0
0
4
0
.
0
8
±
0
.
0
3
0
.
7
±
0
.
3
0
.
0
1
6
±
0
.
0
0
4
0
.
1
0
±
0
.
0
2
0
.
2
0
±
0
.
0
3
0
.
6
±
0
.
2
Aq
ue
ou
s
0
.
2
±
0
.
1
0
.
0
6
±
0
.
0
2
0
.
1
1
±
0
.
0
1
0
.
2
±
0
.
1
0
.
0
4
6
±
0
.
0
0
2
0
.
1
1
±
0
.
0
1
0
.
2
3
±
0
.
0
2
0
.
3
±
0
.
1
𝑃
va
lu
e(
𝑛
=
1
8
)
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
0.
12
2
<
0.
00
1
<
0.
00
1
O
×
E
𝑃
va
lu
e(
𝑛
=
3
6
)
0.
00
1
<
0.
00
1
<
0.
00
1
0.
31
2
<
0.
00
1
<
0.
00
1
0.
05
2
<
0.
00
1
Bi
fo
na
zo
le
0
.
2
0
±
0
.
0
2
0
.
2
0
±
0
.
0
3
0
.
2
0
±
0
.
0
1
0
.
2
0
±
0
.
0
2
0
.
2
0
±
0
.
0
4
0
.
2
5
±
0
.
0
5
0
.
2
5
±
0
.
0
4
0
.
2
0
±
0
.
0
3
Ke
to
co
na
zo
le
0
.
5
0
±
0
.
0
5
0
.
5
0
±
0
.
0
4
2
.
0
±
0
.
4
0
.
5
0
±
0
.
0
5
1
.
0
±
0
.
1
0
.
5
0
±
0
.
0
4
3
.
5
±
0
.
5
0
.
3
0
±
0
.
0
5
1
M
ea
ns
w
ith
in
ac
ol
um
n
w
ith
di
ffe
re
nt
le
tte
rs
di
ffe
rs
ig
ni
fic
an
tly
(𝑃
<
0
.
0
5
).
8 BioMed Research International
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH MeOH
MeOH
MeOH MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
Total phenolics
MFC (P. verrucosum)
Total flavonols
Total flavones MBC (P. aeruginosa)
GI50-Hela
GI50-HepG2
GI50-MCF7
GI-NC-H460
MBC(L. monocytogenes)
MFC (P. ochrochloron)
GI50-HCT15
H2O
H2O
H2O
H2O
H2O
H2O
H2O
H2OH2O
H2O
H2O H2O
H2O
H2O
H2O
H2O H2OH2OMIC (P. Aeruginosa)
GI50-PLP1
MIC (P. ochrochloron) MBC (S. aureus)
MBC (E. cloacae)
MBC (E. coli)
MIC (E. coli)
MIC (L. monocytogenes)
MIC (A. versicolor)
MFC (P. funiculosum)
MFC (A. ochraceus)
MBC (B. cereus)
MBC (S. typhimurium)
MIC (B. cereus) MIC (S. typhimurium)
MIC (E. cloacae)
MIC (S. aureus )
MIC (T. viride)
MFC (T. viride)
MFC (A. versicolor)
MIC (P. funiculosum))
MIC (A. ochraceus)
MFC (A. fumigatus)
MFC (P. verrucosum)
MFC (A. niger)
MIC (A. niger)
MIC (A. fumigatus)
MIC (M. flavus)
MBC (M. flavus)
Total flavan-3-o1
D
im
en
sio
n
2
(3
2
.6
7
%
)
Dimension 1 (40.94%)
1
1
0
0
−1
−1
Figure 1: Biplot of objects (extraction solvents) and component loadings (evaluated parameters).
4. Conclusion
The extract type induced the most marked changes in bioac-
tivity of laurel samples. Furthermore, each of the assayed
factors (origin and extract type) acts in a differentiated man-
ner; that is, the same evaluated parameter gave sometimes
statistically significant differences regarding laurel origin, but
no effect at all from extract type or vice versa. From the PCA
biplot, it became clear that wild laurel samples were more
effective to inhibit tumor cell lines growth, especially HeLa,
MCF7, NCI-H460, and HCT15. HepG2, as previously high-
lighted, had the same reaction to laurel from wild and cul-
tivated origin. It was also observed that methanolic extracts
tended to have higher antimicrobial activity, except A. niger,
A. fumigatus, andP. verrucosum.Thedifferences in bioactivity
might be related to the higher phenolic compounds contents
(mainly flavan-3-ols and flavonols) presented by methanolic
extracts.
The most interesting finding in this work was the bioac-
tive specificity of each laurel extract, considering its wild
or cultivated origin. In fact, from the obtained results it
is possible to choose the combination extract type/origin
with potentially highest effect against determined bacteria,
fungi, or tumor cell line. These findings should, however, be
analysed within the geographical area of study, considering
eventual specific features of the used samples.
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